RD3-MolPack packaging cells for stable production of Tat-independent self-inactivating lentiviral vectors

被引:0
|
作者
Stornaiuolo, A.
Bossi, S.
Corna, S.
Zucchelli, E.
Bordignon, C.
Rizzardi, G. P.
Bovolenta, C.
机构
关键词
D O I
暂无
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
引用
收藏
页码:A95 / A95
页数:1
相关论文
共 43 条
  • [1] Full characterization of the RD3-MolPack packaging cells for the stable production of lentiviral vectors
    Marin, V.
    Piovan, C.
    Corna, S.
    Bossi, S.
    Scavullo, C.
    Giuliani, E.
    Bordignon, C.
    Rizzardi, G. P.
    Bovolenta, C.
    HUMAN GENE THERAPY, 2015, 26 (10) : A69 - A70
  • [2] RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope
    Marin, Virna
    Stornaiuolo, Anna
    Piovan, Claudia
    Corna, Stefano
    Bossi, Sergio
    Pema, Monika
    Giuliani, Erica
    Scavullo, Cinzia
    Zucchelli, Eleonora
    Bordignon, Claudio
    Rizzardi, Gian Paolo
    Bovolenta, Chiara
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2016, 3 : 16033
  • [3] RD3-MolPack technology is an efficient platform for stable production of lentiviral vectors for human hematopoietic stem cells and primary T lymphocytes genetic manipulation
    Marin, Virna
    Scavullo, Cinzia
    Corna, Stefano
    Giuliani, Erica
    Bossi, Sergio
    Stornaiuolo, Anna
    Bordignon, Claudio
    Rizzardi, Gian Paolo
    Bovolenta, Chiara
    HUMAN GENE THERAPY, 2014, 25 (11) : A85 - A85
  • [4] A clinical-grade constitutive packaging cell line for the production of self-inactivating lentiviral vectors
    Knight, Sean
    Sanber, Khaled
    Stephen, Sam
    Bailey, Ranbir
    Escors, David
    Santilli, Giorgia
    Thrasher, Adrian
    Collins, Mary
    Takeuchi, Yasu
    HUMAN GENE THERAPY, 2013, 24 (05) : A23 - A23
  • [5] A clinical-grade constitutive packaging cell line for the production of self-inactivating lentiviral vectors
    Knight, Sean
    Sanber, Khaled
    Stephen, Sam
    Ferraresso, Marta
    Baley, Ranbir
    Escors, David
    Santilli, Giorgia
    Thrasher, Adrian
    Collins, Mary
    Takeuchi, Yasu
    HUMAN GENE THERAPY, 2014, 25 (11) : A101 - A102
  • [6] Insertional Transformation of Hematopoietic Cells by Self-inactivating Lentiviral and Gammaretroviral Vectors
    Modlich, Ute
    Navarro, Susana
    Zychlinski, Daniela
    Maetzig, Tobias
    Knoess, Sabine
    Brugman, Martijn H.
    Schambach, Axel
    Charrier, Sabine
    Galy, Anne
    Thrasher, Adrian J.
    Bueren, Juan
    Baum, Christopher
    MOLECULAR THERAPY, 2009, 17 (11) : 1919 - 1928
  • [7] Vectofusin-1 Significantly Enhances Transduction of Ex-Vivo Activated T Cells With RD114-TR-Pseudotyped Lentiviral Vectors Derived from the RD3-MolPack Stable Packaging Cells
    Marin, Virna
    Corna, Stefano
    Giuliani, Erica
    Scavullo, Cinzia
    Bossi, Sergio
    Bordignon, Claudio
    Galy, Anne
    Rizzardi, Gian Paolo
    Fenard, David
    Bovolenta, Chiara
    MOLECULAR THERAPY, 2015, 23 : S217 - S217
  • [8] Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors
    Schambach, A.
    Mueller, D.
    Galla, M.
    Verstegen, M. M. A.
    Wagemaker, G.
    Loew, R.
    Baum, C.
    Bohne, J.
    GENE THERAPY, 2006, 13 (21) : 1524 - 1533
  • [9] Overcoming promoter competition in packaging cells improves production of self-inactivating retroviral vectors
    A Schambach
    D Mueller
    M Galla
    M M A Verstegen
    G Wagemaker
    R Loew
    C Baum
    J Bohne
    Gene Therapy, 2006, 13 : 1524 - 1533
  • [10] RD2-MolPack-Chim3, a Packaging Cell Line for Stable Production of Lentiviral Vectors for Anti-HIV Gene Therapy
    Stornaiuolo, Anna
    Piovani, Bianca Maria
    Bossi, Sergio
    Zucchelli, Eleonora
    Corna, Stefano
    Salvatori, Francesca
    Mavilio, Fulvio
    Bordignon, Claudio
    Rizzardi, Gian Paolo
    Bovolenta, Chiara
    HUMAN GENE THERAPY METHODS, 2013, 24 (04) : 228 - 240